Unexplored Potential of Traditional Chinese Medicine in Diabetes Mellitus

Abstract

Diabetes is one of the most prevalent disease worldwide and is associated with one of the highest morbidities and mortality rates associated. Like the western and conventional medicines, Traditional Chinese medicine (TCM) has promising results in the ailment of diabetes and its associated complications. But still the use of TCM is refrained for further explorations due to inadequate knowledge of active pharmaceutical ingredient and its isolation. Thus, this review will highlight some of the key concepts and rational behind the therapeutic regimen of TCM aiming towards diabetes treatment. A detailed study of all the articles including research as well as reviews, which were available on the world wide web was performed. The review includes MEDLINE and EMBASE databases using keywords alone or in combinations, such as diabetes, diabetic complications, Chinese therapy, traditional chinese medicine, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic complications, α-amylase and several others. TCM collectively is an effective and comparatively safe in the treatment of diabetes mellitus and its associated complications. Significant results are seen in monotherapy and in combination therapy with current conventional drugs. The effects include controlling glycemic levels along with the mitigation of diabetes associated complications. Focus on clinical trials and further investigations might help in concluding TCM as one of the most effective and safe treatment therapies. TCM holds enormous potential by virtue of its mechanism of action by maintaining the homeostasis in the body and thereby exhibiting pharmacological action.

Chemical Constituents of Artemisia Annua are Potent Inhibitors of Alpha-Amylase in Type II Diabetes

“…Its antimalarial activity is more than any other antimalarial drug. Artemisinin and its derivatives play important role in the treatment of 9 schistosomiasis, hepatitis B , and various cancer cell lines including breast cancer, human leukaemia, [10][11][12] colon and small-cell lung carcinoma. Artemisinin's efficient inhibitory effect on type II diabetes is not yet discovered, so it will be a promising aspect to discover artemisinin's inhibitory effect against diabetes by targeting alpha-amylase.…”

Studies of the Anti-Diabetic Mechanism of Pueraria lobata Based on Metabolomics and Network Pharmacology

“…No matter the therapeutic methods, the propaganda on the prevention of diabetes leaves a lot to be desired [1]. Therefore, traditional Chinese medicine (TCM) with low cost and stable efficacy has become a complementary and alternative medicine for treating DM [2,3].…”